Background. Pulmonary hypertension is associated with abnormal pulmonary arterial contractility and growth. The mechanisms for these abnormalities are largely unknown. To study these processes, we sought to develop an in vitro system. Even though cultured aortic and pulmonary artery smooth muscle cells (SMCs) have been of considerable value in studying smooth muscle biology, one drawback of this system has been that these cells often lose differentiated properties in an unpredictable manner when they are passaged in culture. In addition, there appear to be significant differences in physiological and pathological responses between the systemic and pulmonary circulations, many of which could be directly related to the smooth muscle. We therefore established a cloned population of rat pulmonary arterial SMCs (PASMCs) that maintain differentiated properties through multiple subcultures.
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Circulation Vol 86, No 6 December 1992 nary arterial constriction, whereas they cause systemic arterial dilation. 25 2) Although in utero the pulmonary and systemic circulations are exposed to identical pressures, the former develops far less smooth muscle.26,27 3) Pathological increases in the amount of smooth muscle and connective tissue can occur in the lung at a much faster rate and to a greater degree than in the systemic circulation.28 '29 Although these distinctive features of the pulmonary vasculature may not be solely or directly related to properties of the smooth muscle per se, they raise the possibility that there are significant differences in phenotype and behavior between SMCs of the two vascular beds. 19 We report the isolation of cloned PASMCs that express, through multiple subcultures, functional surface receptors for angiotensin II (Ang II), norepinephrine (NE), and a-thrombin and the smooth muscle isoforms of a-actin, myosin heavy chain (MHC), myosin regulatory light chain (MRLC), and a-tropomyosin (TM) mRNAs.
Methods

Cell Culture
The methods for PASMC isolation and culture were modified from Gunther et al. 30 The main and proximal branch pulmonary arteries of 300-350-g adult male Sprague-Dawley rats (Charles River Laboratories, Wilmington, Mass.) were dissected free and excised. Fat, adventitia, and connective tissue surrounding the arteries were removed by blunt dissection. The cleaned pulmonary arteries were cut into multiple small pieces and incubated for 90 minutes in a 37°C oscillating bath with 0.125 mg/ml elastase (type III, 90 units/mg, Sigma Chemical Co., St. Louis, Mo.), 1 .0 mg/ml collagenase (CLS type I, 150 units/mg, Worthington Biochemical Corp., Freehold, N.J.), 0.250 mg/ml soybean trypsin inhibitor (type 1-S, Sigma), and 2.0 mg/ml crystallized bovine serum albumin (BSA) (Pentex, Miles Laboratories Inc., Elkhardt, Ind.). The tissue suspension was filtered and centrifuged, and the pellet was resuspended in Medium 199 (GIBCO, Grand Island, N.Y.) supplemented with 20% (vol/vol) fetal calf serum (FCS) (GIBCO), 2 mM L-glutamine, 100 units/ml penicillin, and 0.1 mg/ml streptomycin (standard growth media). The cells were incubated in a humidified 5% C02-95% air atmosphere. The medium was changed every other day. PASMCs were harvested with trypsin and passaged when they reached 80-90% confluence. Mouse NIH 3T3 fibroblasts and bovine aortic endothelial cells were used as controls for immunofluorescent staining.
PASMCs were cloned by initially plating 100 subculture 22 cells in a 96-well plate and grown in 50% conditioned: 50% standard growth medium. Conditioned medium was obtained from a dish with PASMCs that were proliferating rapidly in standard growth medium for at least 2 days. Individual cell colonies were subcultured further and characterized. Cloning was started in subculture 22 cells after it was confirmed by extensive characterization that the PASMCs had retained many differentiated properties.
For storage, the cells were harvested with trypsin, centrifuged, and suspended in 10% dimethyl sulfoxide in standard growth medium and immediately frozen at ing standard growth medium, subjected to fresh medium change after 2-3 hours, and used for experiments after three passages. jig COS) was analyzed by S1 protection (as described above) after hybridization with probes specific for the 134 or the 124 splicing pathways. 42 The probes were end-labeled within SV40 sequences to distinguish constructs from endogenous TM transcripts and had a 70-bp, nonhybridizing tail that distinguished true full protection from reannealed probe. Protection patterns using the two probes were visualized by electrophoresis in 5% polyacrylamide denaturing gels followed by autoradiography (12 hours at 20°C for COS, 3-5 days, -80°C with intensifying screens for PAC1).
Results
Cell Culture and Cloning
PASMCs obtained from the main and branch pulmonary arteries of adult Sprague-Dawley rats were enzymatically dissociated and placed in a 35-mm culture dish. After 2 days, the cells began to proliferate, and by 5-6 days, they were nearly confluent. Cells were harvested with trypsin and subcultured in 100-mm dishes at a 1:3 to 1:6 ratio.
To demonstrate that the cultures consisted predominantly of SMCs, immunofluorescent staining was performed with a variety of markers. PASMCs stained uniformly (>98% of cells) with anti-smooth muscle myosin and a-actin antibodies ( Figure 1 , panels A-D). PASMCs did not stain with labeled, acetylated LDL ( Figure 1E ) or anti-factor VIII antibodies (not shown). Endothelial cell controls took up LDL but did not react with the anti-smooth muscle antibodies (not shown). Fibroblasts did not stain with anti-smooth muscle myosin antibodies ( Figure 1F ). The same pattern of staining was replicated in cells that had been subpassaged 23 times. Subculture 46 PASMCs also stained with the anti-smooth muscle antibodies but in a less distinct and fibrillar pattern ( Figure 1G ).
To clone the cells, approximately 100 PASMCs from subculture 22 were grown in a 96-well plate. Four individual cell colonies were obtained and further subcultured. All cloned populations exhibited the characteristic "hill-and-valley" culture morphology and had doubling times similar to uncloned cells. The clones also showed the same immunofluorescent staining pattern with anti-smooth muscle myosin antibodies as the PASMCs of origin even after 53 passages ( Figure 1H ). One of these clones (PAC1) was chosen for further characterization.
Uncloned PASMCs and PAC1 cells have been maintained in culture for >400 doubling times (100 subpassages). In 20% FCS, both PASMCs and PAC1 cells had a doubling time of approximately 24 hours, and in 0.5% FCS (serum deprivation), there was no significant increase in cell number (Figure 2 Actin. Total RNA from PASMCs was hybridized with a rat vascular a-actin probe, which cross-reacts with the /3/y-isoforms of actin ( Figure 4A ) as well as the smooth muscle a-isoform of actin ( Figure 4B ). There was no significant change in the fP3/y-mRNAs (confluence mRNA level, 79±18% of subconfluence; n=3,p>0.05), but there was a 115±83% increase (n=4,p<0.05) in the a-smooth muscle actin mRNA as the cells progressed from subconfluence to confluence (Figure 4 ). Hybrid- Tim (mnfutes) mRNAs to 12±4% of subconfluent levels (n=2, p<0.005) ( Figure 5A ). Hybridization of RNA from PAC1 cells with a probe derived from the 3' untranslated region of the a-smooth muscle actin isoform, which is specific for the a-isoform, showed an increase of 120±49% (n=4, p<0.01) in smooth muscle a-actin mRNA as cells reached confluence ( Figure 5B ). MHC. RNA from PASMCs and PAC1 cells was hybridized with a cDNA probe encoding a rat aortic smooth muscle MHC isoform. This probe specifically identifies the smooth muscle isoform of MHC.39 Smooth muscle MHC mRNA increased 1,140±670% in the PASMCs (n=3,p<0.05) and 1,870±390% in the PAC1 cells (n = 2, p <0.05) from subconfluence to confluence ( Figures 4C and SC) .
MRLC. SMCs express two highly homologous MRLC mRNAs.48 Neither MRLC is specific for smooth muscle, and both are expressed in smooth muscle and nonmuscle cells. Using a probe (MRLC 2) that recognizes both isoforms, PASMC showed a 120±44% increase (n=3, p<0.025) ( Figure 4D ), whereas PAC1 cells showed no significant change (confluence mRNA level, 126±98% of subconfluence; n =3, p>0.05) ( Figure SD) (Figure 8 ). In contrast, transfected COS cells displayed almost complete inclusion of exon 3, the expected non-smooth muscle pattern (Figure 8) . The smooth muscle cDNA Eco RI-PstI restriction fragment with a polylinker tail (hatched) depicted at the top right was 5' end-labeled at a nucleotide corresponding to codon 120 (see also Figure 7 
